Drugs makers talk fusion

PHARMACEUTICAL manufacturer Slovakofarma and Czech pharmaceutical giant Leživa Praha may soon belong to the same company.

Warburg Pincus, an American fund and current owner of Leživa, has expressed interest in acquiring a majority share in Slovakofarma. The deal awaits the approval of both the Czech and Slovak anti-monopoly offices.

According to Leživa general director Jiři Michal, "The synergy from the union should mean that we concentrate our resources on speeding up our innovative activities."

If the purchase is approved, the combined group will be one of the five largest firms in central Europe.

Get daily Slovak news directly to your inbox

Top stories

Nationwide testing - an ambitious plan with an uncertain result

Antigen tests to be used work on patients with symptoms.

Police arrest top special prosecutor, suspected of helping a mafia group

Dušan Kováčik is known for not filing any criminal lawsuits.

How many people were infected in Volkswagen or U.S. Steel? Top companies mostly remain silent

Biggest employers have introduced measures, they do not want to talk about possible layoffs.

The Bratislava plant of Volkswagen maintained strict measures also in the summer.

The cabinet approves plan for permanent kurzarbeit

The new fund is expected to be introduced from 2022.

Labour Minister Milan Krajniak